TriVascular Technologies Priced, Nasdaq: TRIV
Markets the smallest and most versatile stent grafts for endovascular aortic repair.
Industry: Health Care
First Day Return: +14.9%
Industry: Health Care
TRIV
Markets the smallest and most versatile stent grafts for endovascular aortic repair.
| IPO Data | |
|---|---|
| IPO File Date | 03/10/2014 |
| Offer Price | $12.00 |
| Price Range $13.00 - $15.00 | |
| Offer Shares (mm) | 6.5 |
| Deal Size ($mm) | $78 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 04/15/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $78 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Santa Rosa, CA, United States |
| Founded | 1998 |
| Employees at IPO | 253 |
| Website www.trivascular.com | |
IPO News for TriVascular Technologies
TriVascular Technologies (TRIV) Performance
